Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
The increasing number of patients with sequenced prostate cancer genomes enables us to study not only individual oncogenic mutations, but also capture the global burden of genomic alterations. Here we review the extent of tumor genome mutations and chromosomal structural variants in various clinical...
Main Authors: | Matthew J. Ryan, Rohit Bose |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01287/full |
Similar Items
-
A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma
by: Luochengling Xiang, et al.
Published: (2020-09-01) -
Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
by: Joan C Smith, et al.
Published: (2018-12-01) -
Diverse immune response of DNA damage repair-deficient tumors
by: Tao Qing, et al.
Published: (2021-05-01) -
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
by: Haley Hieronymus, et al.
Published: (2018-09-01) -
Association Analysis of Somatic Copy Number Alteration Burden With Breast Cancer Survival
by: Linfan Zhang, et al.
Published: (2018-10-01)